Blood pressure management after endovascular therapy

Affiliations

¹ Department of Neurology, Division of Neurocritical Care, Johns Hopkins University, Baltimore, MD 21287, USA. Electronic address: weziai@jhmi.edu.
² Department of Neurology, Division of Neurocritical Care, Johns Hopkins University, Baltimore, MD 21287, USA.

Comment

Wendy C Ziai et al. Lancet Neurol. 2021 Apr.

. 2021 Apr;20(4):248-249.

doi: 10.1016/S1474-4422(21)00058-2. Epub 2021 Feb 26.

¹ Department of Neurology, Division of Neurocritical Care, Johns Hopkins University, Baltimore, MD 21287, USA. Electronic address: weziai@jhmi.edu.
² Department of Neurology, Division of Neurocritical Care, Johns Hopkins University, Baltimore, MD 21287, USA.

No abstract available

Comment on

Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial.
Mazighi M, Richard S, Lapergue B, Sibon I, Gory B, Berge J, Consoli A, Labreuche J, Olivot JM, Broderick J, Duhamel A, Touze E, Qureshi AI, Yavchitz A, Escalard S, Desilles JP, Redjem H, Smajda S, Fahed R, Hébert S, Maïer B, Delvoye F, Boursin P, Maacha MB, Obadia M, Sabben C, Blanc R, Savatovsky J, Piotin M; BP-TARGET investigators. Mazighi M, et al. Lancet Neurol. 2021 Apr;20(4):265-274. doi: 10.1016/S1474-4422(20)30483-X. Epub 2021 Feb 26. Lancet Neurol. 2021. PMID: 33647246 Clinical Trial.